Stockscreener 앱 받기
0.37
0.00%
0.002
Immutep Limited Adr 주식(IMMP)의 최신 뉴스
IMMP Investor News: If You Have Suffered Losses in Immutep Ltd. (NASDAQ: IMMP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - mykxlg.com
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Immutep (NASDAQ: IMMP) reports positive Phase I progress for LAG-3 agonist IMP761 - Stock Titan
IMMP Investor News: If You Have Suffered Losses in Immutep - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - PR Newswire
On Wednesday, there are stocks with unusual volume. Let's take a look. - ChartMill
IMMP Investor Alert: Immutep Ltd. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Management Allegedly Misrepresented Trial Progress: Levi & Korsinsky - Sahm
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - FinancialContent
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action Investigation – IMMP - Business Wire
On Tuesday, there are stocks with unusual volume. Let's take a look. - ChartMill
IMM:ASX AnnouncementChange in substantial holding17 Mar 2026 - Market Index
[6-K] IMMUTEP Ltd Current Report (Foreign Issuer) | IMMP SEC FilingForm 6-K - Stock Titan
Crude Oil Gains Over 1%; VEON Shares Spike Higher - Sahm
Immutep Stock Tanks After Futility Analysis Ends Key Lung Cancer Trial Early - Sahm
This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4 - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
United States shares lower at close of trade; Dow Jones Industrial Average down 0.25% By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com UK
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com
This EverCommerce analyst is no longer bullish; here are top 5 downgrades for Friday - MSN
This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
US Market Preview | PCE in Line; ISPC Soars 86.7%; Oil Spikes Amid Iran’s Leader Talk; AI Wealth Boom Adds 45 Billionaires - Sahm
Orchestra BioMed (NASDAQ:OBIO) versus Prima BioMed (NASDAQ:IMMP) Critical Analysis - Defense World
Immutep reports positive phase I data for first-in-class autoimmune antibody IMP761 - MSN
Why Immutep Limited (Common Stock) (YP1A) stock is trending on social mediaHealthcare Stock Analysis & Investment Portfolio Recommendations - Bollywood Helpline
Immutep (IMMP) reports positive IMP761 Phase I study update - Stock Titan
Why Wall Street Is Watching Immutep's Experimental Autoimmune Treatment Closely - Sahm
Will Immutep Limited Depositary Receipt stock see insider buying2025 Bull vs Bear & Accurate Intraday Trading Signals - Улправда
Why Immutep Limited (YP1B) stock is a strong analyst pickWeekly Risk Summary & AI Powered Trade Plan Recommendations - Улправда
Immutep Limited (IMMP): Firm Reports Positive Data from Trials - Finviz
Ready to Jump After Recent Trade: Beta Bionics Inc (BBNX) - setenews.com
An analyst sees good growth prospects for Immutep Limited ADR (IMMP) - setenews.com
Immutep Limited Announces 2025 AGM with Key Resolutions - MSN
IMMP 20-F highlights: pipeline progress, IFRS results, Nasdaq ADSs - Stock Titan
Immutep reports Phase II neoadjuvant efti success in sarcoma via 6-K - Stock Titan
Immutep Completes FDA Project Optimus, Advances Cancer Immunotherapy - MSN
Immutep files 6-K with exhibit on FDA Project Optimus completion - Stock Titan
Immutep Announces Successful Completion of FDA Project Optimus Requirements - The Manila Times
Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa - Yahoo Finance
Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data - Finviz
Immutep stock soars on promising trial results By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ: IMMP)Share Price - intelligentinvestor.com.au
JK Paper slides over 7% after Q1 net profit declines 55% YoY to ₹140.79 crore - Upstox
0.99%
3.03%
자본화:
|
볼륨(24시간):